Want an argument then you need to change topics Peet. No real evidence but get the impression Elanco & Lilly still have a bit of cleaning up to do and there is some sort of external legal stoush going on etc etc. In addition as mentioned previously by others there is a need to be mindful of what is announced / trumpeted to the market on the PAA side that may impact Elancos SP so basically all in all a complex set of circumstances. I am pretty sure though that there are some serious conversations being had. Would not surprise (again absolutely no evidence) if somehow there is consideration for the PAA scientists to continue running almost on a caretaker sort of basis until all the ducks are lined up. No conspiracy theory or wrongdoing suspected but just commercial reality regards timing of a bigger picture. I came in to this for the end game (have bought more but not sold any) and have absolutely no reason to change my position - but good luck to those who have a different position.
- Forums
- ASX - By Stock
- Ann: Preliminary Positive Results for the Treatment of SARS-CoV-2
Want an argument then you need to change topics Peet . No real...
-
- There are more pages in this discussion • 212 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $50.92K | 290.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 152309 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 329859 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 152309 | 0.175 |
13 | 381650 | 0.170 |
7 | 256513 | 0.165 |
8 | 396304 | 0.160 |
6 | 336734 | 0.155 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 329859 | 3 |
0.185 | 267471 | 5 |
0.190 | 722743 | 7 |
0.195 | 575777 | 10 |
0.200 | 302726 | 11 |
Last trade - 15.48pm 11/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |